SCHEMBL19906059

SCHEMBL19906059

Cc1cc2nc(-c3ccnc(-c4cncc(C(N)=O)c4)c3)sc2c(-c2ccc(Cl)cc2OC(C)(C)C)c1CC(=O)O

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
KMT2A Q03164 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
CTSA P10619 2/20 0.33
MAP4K4 O95819 1/20 0.33
ALPL P05186 2/20 0.32
DRD1 P21728 1/20 0.32
CDC7 O00311 2/20 0.31
DBF4 Q9UBU7 2/20 0.31
CCNE1 P24864 1/20 0.31
CDK2 P24941 1/20 0.31
SHMT1 P34896 2/20 0.31
ROS1 P08922 1/20 0.31
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19906328 0.94 PTGER1 (0.34) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906044 0.92 SHMT1 (0.38) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19905772 0.88 MAP4K4 (0.41) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906369 0.87 KDM4E (0.38) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906229 0.86 EIF4E (0.36) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906366 0.85 CTSA (0.34) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906268 0.85 EIF4E (0.38) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906288 0.84 CSF1R (0.35) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906122 0.84 KDM4C (0.34) KDM4EMEN1ALDH1A1KMT2APTGDR2
SCHEMBL19906211 0.84 KDM4E (0.34) KDM4EMEN1ALDH1A1KMT2APTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3070081-B1 BENZOTHIAZOL-6-YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION GILEAD SCIENCES INC (US) 2018-02-28 EP disclosed